Finance

Beta
Lists
NKGN:OTCMKTS
NKGen Biotech Inc
$0.060
0.00%
(0.00) 1D
Jun 12, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NKGN...
Open
$0.06
High
$0.06
Low
$0.06
Mkt. cap
7.84M
Avg. vol.
3.48K
Volume
21.17K
52-wk high
$0.38
52-wk low
$0.00
Beta
1.27
Shares outstanding
130.60M
No. of employees
26
Open
$0.06
High
$0.06
Low
$0.06
Mkt. cap
7.84M
Avg. vol.
3.48K
Volume
21.17K
52-wk high
$0.38
52-wk low
$0.00
Beta
1.27
Shares outstanding
130.60M
No. of employees
26
News stories
From sources across the web
About NKGen Biotech Inc
CEO-
Employees26
Founded2017
HeadquartersSanta Ana, California, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.09M
2.78M
1.56M
1.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.37M
4.01M
3.54M
2.81M
Operating expense
7.46M
6.79M
5.10M
4.67M
Total operating expenses
7.46M
6.79M
5.10M
4.67M
Operating income
-7.46M
-6.79M
-5.10M
-4.67M
Other non operating income
-18.38M
-2.99M
-8.79M
20.52M
EBT including unusual items
-16.09M
6.60M
-29.36M
15.35M
EBT excluding unusual items
-26.48M
-10.25M
-14.43M
15.35M
Income tax expense
-
-
53.00K
-
Effective tax rate
-
-
-0.18%
-
Other operating expenses
-
-
-
-
Net income
-16.09M
6.60M
-29.41M
15.35M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-647.00K
-472.00K
-536.00K
-509.00K
Net interest expenses
-647.00K
-472.00K
-536.00K
-509.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.16M
-6.49M
-4.80M
-4.32M
Gain or loss from assets sale
1.00K
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more